Gene_set	Pathway	Overlap	P-value	Adjusted P-value	Odds Ratio	Combined Score	Genes
KEGG_2021_Human	Inflammatory bowel disease	3/65	5.7322256772471596e-05	0.002235568014126392	55.34101382488479	-100.98537671170521	IL17A;IL1B;IL6
KEGG_2021_Human	Legionellosis	3/57	3.859950954844004e-05	0.002235568014126392	63.6031746031746	-112.5302356283168	CASP9;IL1B;IL6
KEGG_2021_Human	Rheumatoid arthritis	3/93	0.00016720908178540931	0.0033658679727576507	37.99047619047619	-74.4091590745228	IL17A;IL1B;IL6
KEGG_2021_Human	IL-17 signaling pathway	3/94	0.00017260861398757182	0.0033658679727576507	37.56828885400314	-73.71479219141467	IL17A;IL1B;IL6
KEGG_2021_Human	Th17 cell differentiation	3/107	0.0002534260244380865	0.003953445981234149	32.81868131868132	-65.71442008901244	IL17A;IL1B;IL6
KEGG_2021_Human	Measles	3/139	0.0005476317685268026	0.0068756050137535486	24.99579831932773	-51.672386684351224	CASP9;IL1B;IL6
KEGG_2021_Human	PI3K-Akt signaling pathway	4/354	0.0006170414755932672	0.0068756050137535486	14.700952380952382	-40.688114366493096	CASP9;COL9A2;COL9A3;IL6
KEGG_2021_Human	Influenza A	3/172	0.001019644326496313	0.008249765997632602	20.0312764158918	-42.078889135072146	CASP9;IL1B;IL6
KEGG_2021_Human	Graft-versus-host disease	2/42	0.0011566808072543669	0.008249765997632602	50.175	-57.95352918467438	IL1B;IL6
KEGG_2021_Human	Tuberculosis	3/180	0.0011634285381276748	0.008249765997632602	19.106537530266344	-40.222430877266724	CASP9;IL1B;IL6
KEGG_2021_Human	African trypanosomiasis	2/37	0.0008976760152685225	0.008249765997632602	57.378571428571426	-64.24352876962546	IL1B;IL6
KEGG_2021_Human	Pathogenic Escherichia coli infection	3/197	0.0015104299457678824	0.009817794647491235	17.394698085419734	-36.72187076283526	CASP9;IL1B;IL6
KEGG_2021_Human	Malaria	2/50	0.0016370061401984127	0.009822036841190476	41.770833333333336	-50.1560330081587	IL1B;IL6
KEGG_2021_Human	Lipid and atherosclerosis	3/215	0.0019428303639941794	0.010824340599396142	15.881401617250674	-33.55383703082171	CASP9;IL1B;IL6
KEGG_2021_Human	Human cytomegalovirus infection	3/225	0.00221350447353219	0.011510223262367386	15.146718146718147	-31.989452913184095	CASP9;IL1B;IL6
KEGG_2021_Human	Cytosolic DNA-sensing pathway	2/63	0.00258752682682323	0.012614193280763245	32.8155737704918	-41.182346051003734	IL1B;IL6
KEGG_2021_Human	Pertussis	2/76	0.0037436519554145367	0.01663903844580347	27.006756756756758	-34.90410589940028	IL1B;IL6
KEGG_2021_Human	Prion disease	3/273	0.0038397781028777236	0.01663903844580347	12.377777777777778	-25.926933584065353	CASP9;IL1B;IL6
KEGG_2021_Human	ECM-receptor interaction	2/88	0.0049885835861889025	0.01945547598613672	23.203488372093023	-30.553595052356073	COL9A2;COL9A3
KEGG_2021_Human	Cytokine-cytokine receptor interaction	3/295	0.004778958454651453	0.01945547598613672	11.412915851272016	-23.74866982495136	IL17A;IL1B;IL6
KEGG_2021_Human	Hematopoietic cell lineage	2/99	0.006275930773922806	0.01995182057025814	20.54381443298969	-27.37901341152302	IL1B;IL6
KEGG_2021_Human	AGE-RAGE signaling pathway in diabetic complications	2/100	0.006399778215208473	0.01995182057025814	20.331632653061224	-27.120602948412195	IL1B;IL6
KEGG_2021_Human	Protein digestion and absorption	2/103	0.006778064196695983	0.01995182057025814	19.72029702970297	-26.371589917244943	COL9A2;COL9A3
KEGG_2021_Human	Chagas disease	2/102	0.006650847322673755	0.01995182057025814	19.92	-26.61700675496218	IL1B;IL6
KEGG_2021_Human	C-type lectin receptor signaling pathway	2/104	0.006906399428166279	0.01995182057025814	19.524509803921568	-26.130280011490946	IL1B;IL6
KEGG_2021_Human	Toll-like receptor signaling pathway	2/104	0.006906399428166279	0.01995182057025814	19.524509803921568	-26.130280011490946	IL1B;IL6
KEGG_2021_Human	Amoebiasis	2/102	0.006650847322673755	0.01995182057025814	19.92	-26.61700675496218	IL1B;IL6
KEGG_2021_Human	TNF signaling pathway	2/112	0.007973056255711614	0.022210656712339495	18.086363636363636	-24.33571316400054	IL1B;IL6
KEGG_2021_Human	Alzheimer disease	3/369	0.008924054845697141	0.02400263027463369	9.018735362997658	-18.187178129854335	CASP9;IL1B;IL6
KEGG_2021_Human	Yersinia infection	2/137	0.011753397776716717	0.030558834219463465	14.690740740740742	-19.931093924152265	IL1B;IL6
KEGG_2021_Human	Non-alcoholic fatty liver disease	2/155	0.014879426053803059	0.037438555877310924	12.933006535947712	-17.54750234216727	IL1B;IL6
KEGG_2021_Human	Hepatitis B	2/162	0.016183180370760934	0.03944650215372978	12.35625	-16.748364182562245	CASP9;IL6
KEGG_2021_Human	Pathways of neurodegeneration	3/475	0.017772166326566263	0.04200693859006571	6.897094430992736	-13.07371705691191	CASP9;IL1B;IL6
KEGG_2021_Human	Herpes simplex virus 1 infection	3/498	0.020174850542549024	0.044961095494823536	6.556709956709956	-12.239051897711217	CASP9;IL1B;IL6
KEGG_2021_Human	NOD-like receptor signaling pathway	2/181	0.019962543247368986	0.044961095494823536	11.018156424581006	-14.859767863470836	IL1B;IL6
KEGG_2021_Human	Kaposi sarcoma-associated herpesvirus infection	2/193	0.02252556995474682	0.0488054015686181	10.31020942408377	-13.840129933766221	CASP9;IL6
KEGG_2021_Human	Focal adhesion	2/201	0.02430775457262447	0.05036048564880047	9.885678391959798	-13.221635183162709	COL9A2;COL9A3
KEGG_2021_Human	Epstein-Barr virus infection	2/202	0.024534595572492535	0.05036048564880047	9.835	-13.147442958027579	CASP9;IL6
KEGG_2021_Human	Coronavirus disease	2/232	0.03174764714886429	0.06349529429772859	8.519565217391305	-11.194266119915625	IL1B;IL6
KEGG_2021_Human	Salmonella infection	2/249	0.03617242514905692	0.07053622904066101	7.915991902834008	-10.280113155611538	IL1B;IL6
KEGG_2021_Human	Type I diabetes mellitus	1/43	0.052002121863896134	0.09893086598497312	21.232804232804234	-12.171283962486152	IL1B
KEGG_2021_Human	Intestinal immune network for IgA production	1/48	0.05788809587819119	0.10750646377378364	18.962174940898347	-11.032973182262484	IL6
KEGG_2021_Human	Human papillomavirus infection	2/331	0.06060431633754296	0.10993341103089187	5.880699088145897	-7.115618067766183	COL9A2;COL9A3
KEGG_2021_Human	Viral myocarditis	1/60	0.07188046794101291	0.12188427172606536	15.08286252354049	-8.981081638876871	CASP9
KEGG_2021_Human	VEGF signaling pathway	1/59	0.07072162222736704	0.12188427172606536	15.344827586206897	-9.124402207995153	CASP9
KEGG_2021_Human	Endometrial cancer	1/58	0.06956147443988561	0.12188427172606536	15.61598440545809	-9.271975415581295	CASP9
KEGG_2021_Human	Non-small cell lung cancer	1/72	0.0856855265026792	0.14109478998408218	12.514866979655713	-7.534346814915346	CASP9
KEGG_2021_Human	p53 signaling pathway	1/73	0.0868275630671275	0.14109478998408218	12.339506172839506	-7.43259286356604	CASP9
KEGG_2021_Human	Pancreatic cancer	1/76	0.09024597396088518	0.14255729633551803	11.841481481481482	-7.141387005986298	CASP9
KEGG_2021_Human	Leishmaniasis	1/77	0.09138288226635771	0.14255729633551803	11.68421052631579	-7.04872976578505	IL1B
KEGG_2021_Human	Colorectal cancer	1/86	0.10155766145487406	0.1553234822251015	10.435294117647059	-6.300464747037211	CASP9
KEGG_2021_Human	Hypertrophic cardiomyopathy	1/90	0.10604677818396174	0.15907016727594261	9.961298377028713	-6.010407578745034	IL6
KEGG_2021_Human	Small cell lung cancer	1/92	0.10828375753966943	0.159361001662155	9.739926739926739	-5.8737398650795125	CASP9
KEGG_2021_Human	Inflammatory mediator regulation of TRP channels	1/98	0.11496450084552494	0.16304056483547172	9.130584192439862	-5.49346810373269	IL1B
KEGG_2021_Human	Prostate cancer	1/97	0.11385418156418702	0.16304056483547172	9.226851851851851	-5.553951626329874	CASP9
KEGG_2021_Human	Viral protein interaction with cytokine and cytokine receptor	1/100	0.11718138394436346	0.16321692763679196	8.94388327721661	-5.375723879218761	IL6
KEGG_2021_Human	NF-kappa B signaling pathway	1/104	0.12160016340314761	0.16640022360430726	8.592233009708737	-5.152341092635986	IL1B
KEGG_2021_Human	HIF-1 signaling pathway	1/109	0.1270956407872156	0.1680247454475054	8.189300411522634	-4.893732148578802	IL6
KEGG_2021_Human	Insulin resistance	1/108	0.12599902727061665	0.1680247454475054	8.2668743509865	-4.943743954376122	IL6
KEGG_2021_Human	Toxoplasmosis	1/112	0.13037805537365837	0.16949147198575587	7.964964964964965	-4.748494648054986	CASP9
KEGG_2021_Human	Pathways in cancer	2/531	0.13679480156092927	0.1749179429795489	3.5628544423440456	-3.410136075895621	CASP9;IL6
KEGG_2021_Human	Thyroid hormone signaling pathway	1/121	0.14015875566728583	0.17632875712981122	7.359259259259259	-4.351741094826131	CASP9
KEGG_2021_Human	Osteoclast differentiation	1/127	0.1466241030974613	0.18153460383495207	7.00352733686067	-4.115510268264927	IL1B
KEGG_2021_Human	FoxO signaling pathway	1/131	0.1509099928727911	0.18392155381371417	6.7846153846153845	-3.968927686510734	IL6
KEGG_2021_Human	Fluid shear stress and atherosclerosis	1/139	0.15942370386618251	0.191308444639419	6.384863123993559	-3.698840756963446	IL1B
KEGG_2021_Human	Apoptosis	1/142	0.16259648475288416	0.19215948198068128	6.2466509062253746	-3.6047270952512624	CASP9
KEGG_2021_Human	Necroptosis	1/159	0.18037286671285227	0.2038997623710504	5.562587904360056	-3.1333425612983894	IL1B
KEGG_2021_Human	Hepatitis C	1/157	0.17829930575122027	0.2038997623710504	5.635327635327635	-3.183908163692195	CASP9
KEGG_2021_Human	Cellular senescence	1/156	0.17726075583432344	0.2038997623710504	5.672401433691756	-3.209640069203435	IL6
KEGG_2021_Human	JAK-STAT signaling pathway	1/162	0.18347437883820783	0.20444287927686014	5.456866804692892	-3.0596637281364782	IL6
KEGG_2021_Human	Transcriptional misregulation in cancer	1/192	0.21391358807496763	0.23500366013869683	4.5823152995927865	-2.441961042053517	IL6
KEGG_2021_Human	Human immunodeficiency virus 1 infection	1/212	0.23363497492364255	0.2531045561672794	4.137440758293839	-2.12256354972075	CASP9
KEGG_2021_Human	Human T-cell leukemia virus 1 infection	1/219	0.24043153000367978	0.25689944301763046	4.001019367991845	-2.0240281738454993	IL6
KEGG_2021_Human	Shigellosis	1/246	0.26614163456811335	0.2797073811107906	3.547845804988662	-1.6951894904190261	IL1B
KEGG_2021_Human	Parkinson disease	1/249	0.2689494049142217	0.2797073811107906	3.503584229390681	-1.6629804039719844	CASP9
KEGG_2021_Human	MAPK signaling pathway	1/294	0.3099217585428667	0.3180775942939948	2.9484262419416005	-1.2588658824557653	IL1B
KEGG_2021_Human	Huntington disease	1/306	0.32049274018188956	0.32465498356087513	2.8280510018214935	-1.1715156192121785	CASP9
KEGG_2021_Human	Amyotrophic lateral sclerosis	1/364	0.3695602254440061	0.3695602254440061	2.3584328129782675	-0.8341701676241932	CASP9
